Effects of the Consumption of Broccoli Sprouts in Overweight Subjects (SPROUTvsFAT)
Obesity, Inflammation

About this trial
This is an interventional prevention trial for Obesity focused on measuring IL-6, Glucosinolate, Brassica oleracea, Sulphoraphane, Biomarkers, Bioavailability, Inflammation
Eligibility Criteria
Inclusion Criteria:
BMI within the overweight range according to the World Health Organization criteria (24.9-29.9 kg/m2), aged 35-55 years, taking no vitamins, supplements or medication during the previous two months; no-smoking.
Exclusion Criteria:
Diagnosed diseases as hypertension and cardiovascular pathologies, diabetes, hepatic, gastrointestinal and renal diseases, as well as the intake of drugs related to these pathologies, vegetarian diet, pregnancy or breastfeeding.
Sites / Locations
Arms of the Study
Arm 1
Experimental
Broccoli sprout and follow up
Daily consumption of 30 g of raw, fresh, broccoli sprouts, not cooked, during 10 weeks (70 days), followed by other 90 days of no ingestion of broccoli sprouts